Venous thromboembolic disease and hematologic considerations in obesity

Critical Care Clinics

Volumn 26, Issue 4, 2010, Pages 637-640

  Craft, Mitchell K ^a   Reed, Mary Jane ^b  

^a GEISINGER MEDICAL CENTER   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipocytes; Obesity; PAI 1; Pulmonary embolism; Venous thromboembolism

Indexed keywords

ADIPONECTIN; ANTICOAGULANT AGENT; HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANTICOAGULANT THERAPY; BODY MASS; BOOK; COMPRESSION THERAPY; CRITICALLY ILL PATIENT; DEEP VEIN THROMBOSIS; HUMAN; LUNG EMBOLISM; NONHUMAN; OBESITY; PRIORITY JOURNAL; RISK FACTOR; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 77958107901     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2010.06.011     Document Type: Review

References (24)

1. Geerts W., Bergqvist D., Pineo G., et al. Prevention of venous thromboembolism the seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest 2006, 126(3):338S-400S.
2. Hirsch D.R., Ingenito E.P., Goldhaber S.Z. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 1995, 274:335-337.
3. Marik P.E., Andrews L., Maini B. The incidence of deep venous thrombosis in ICU patients. Chest 1997, 111:661-664.
4. Stein P., Henry J. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995, 108(4):978-981.
5. Moser K.M., LeMoine J.R., Nachtwey F.J., et al. Deep venous thrombosis and pulmonary embolism: frequency in a respiratory intensive care unit. JAMA 1981, 246:1422-1424.
6. Neuhaus A., Bentz R.R., Weg J.G. Pulmonary embolism in respiratory failure. Chest 1978, 73:460-465.
7. Borch K., Braekkan S., Mathiesen E., et al. Anthropometric measures of obesity and risk of venous thromboembolism. Arterioscler Thromb Vasc Biol 2010, 30:121-127.
8. Stein P., Beemath A., Olson R. Obesity as a risk factor in venous thromboembolism. Am J Med 2005, 118:978-980.
9. Goldhaber S., Grodstein F., Stampfer M., et al. A prospective study of risk factors for pulmonary embolism in women. JAMA 1997, 277(8):642-645.
10. Hansson P., Welin L., Tibblin G., et al. Deep vein thrombosis and pulmonary embolism in the general population " The study of Men born in 1913" Arch Intern Med 1997, 157(15):1665-1670.
11. Eichenger S., Hron G., Bialonczyk C., et al. Overweight, obesity and the risk of recurrent venous thromboembolism. Arch Intern Med 2008, 168(15):1678-1683.
12. Barba R., Zapatero A., Losa J.E., et al. Body mass index and mortality in patients with acute venous thromboembolism: findings from the RIETE registry. J Thromb Haemost 2008, 6(4):595-600.
13. Geerts W., Code K., Jay R., et al. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994, 331:1601-1606.
14. Sartori M.T., Danesin C., Saggiorato G., et al. The PAI-1 gene 4 G/5 G polymorphism and deep vein thrombosis in patients with inherited thrombophilia. Clin Appl Thromb Hemost 2003, 9(4):299-307.
15. Loskutoff D., Samad F. The adipocyte and hemostatic balance in obesity studies of PAI-1. Arterioscler Thromb Vasc Biol 1998, 18:1-6.
16. Levi M., Biemond B.J., van Zonneveld A.J., et al. Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis. Circulation 1992, 85:305-312.
17. Alessi M., Vague I. PAI-1 and the metabolic syndrome links, causes and consequence. Arterioscler Thromb Vasc Biol 2006, 26:2200-2207.
18. Kato H., Kashiwagi H., Shiraga M., et al. Adiponectin acts as an endogenous antithrombotic factor. Arterioscler Thromb Vasc Biol 2006, 26(1):224-230.
19. Basili S., Pacini G., Guagnano M.T., et al. Insulin resistance as a determinant of platelet activation in obese women. J Am Coll Cardiol 2006, 48(12):2531-2538.
20. Mertens I., Van Gaal L.F. Obesity, haemostasis and the fibrinolytic system. Obes Rev 2002, 3(2):85-101.
21. Warlow C., McNeill A., Ogston D., et al. Platelet adhesiveness, coagulation and fibrinolytic activity in obesity. J Clin Pathol 1972, 25:484-486.
22. Carmeliet P., Schoonjans L., Kieckens L., et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994, 368(6470):419-424.
23. Van Guilder G., Hoetzer G., Smith D., et al. Endothelial t-PA release is impaired in overweight and obese adults but can be improved with regular aerobic exercise. Am J Physiol Endocrinol Metab 2005, 289:807-813.
24. Overby D.W., Kohn G.P., Cahan M.A., et al. Prevalence of thrombophilias in patients presenting for bariatric surgery. Obes Surg 2009, 19(9):1278-1285.